{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:19:14Z","timestamp":1784852354057,"version":"3.55.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hormones"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.14310\/horm.2002.1448","type":"journal-article","created":{"date-parts":[[2014,2,10]],"date-time":"2014-02-10T12:33:18Z","timestamp":1392035598000},"page":"591-597","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Sequential treatment with teriparatide and strontium ranelate in a postmenopausal woman with atypical femoral fractures after long-term bisphosphonate administration"],"prefix":"10.1007","volume":"12","author":[{"given":"Kalliopi","family":"Lampropoulou-Adamidou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Symeon","family":"Tournis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexia","family":"Balanika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioulia","family":"Antoniou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis P.","family":"Stathopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Baltas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis K.","family":"Triantafillopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos A.","family":"Papaioannou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,10,1]]},"reference":[{"key":"12040591_CR1","doi-asserted-by":"publisher","first-page":"96","DOI":"10.14310\/horm.2002.1226","volume":"8","author":"PD Papapetrou","year":"2009","unstructured":"Papapetrou PD, 2009 Bisphosphonate-associated adverse events. Hormones (Athens) 8: 96\u2013110.","journal-title":"Hormones (Athens)"},{"key":"12040591_CR2","doi-asserted-by":"publisher","first-page":"2951","DOI":"10.1007\/s00198-011-1804-x","volume":"22","author":"J Compston","year":"2011","unstructured":"Compston J, 2011 Pathophysiology of atypical femoral fractures and osteonecrosis of the jaw. Osteoporos Int 22: 2951\u20132961.","journal-title":"Osteoporos Int"},{"key":"12040591_CR3","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1002\/jbmr.253","volume":"25","author":"E Shane","year":"2010","unstructured":"Shane E, Burr D, Ebeling PR, et al, 2010 Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 25: 2267\u20132294.","journal-title":"J Bone Miner Res"},{"key":"12040591_CR4","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1210\/jc.2010-2520","volume":"96","author":"SJ Gomberg","year":"2011","unstructured":"Gomberg SJ, Wustrack RL, Napoli N, Arnaud CD, Black DM, 2011 Teriparatide, vitamin D, and calcium healed bilateral subtrochanteric stress fractures in a postmenopausal woman with a 13-year history of continuous alendronate therapy. J Clin Endocrinol Metab 96: 1627\u20131632.","journal-title":"J Clin Endocrinol Metab"},{"key":"12040591_CR5","doi-asserted-by":"publisher","first-page":"2675","DOI":"10.1210\/jc.2011-0593","volume":"96","author":"NN Carvalho","year":"2011","unstructured":"Carvalho NN, Voss LA, Almeida MO, Salgado CL, Bandeira F, 2011 Atypical femoral fractures during prolonged use of bisphosphonates: short-term responses to strontium ranelate and teriparatide. J Clin Endocrinol Metab 96: 2675\u20132680.","journal-title":"J Clin Endocrinol Metab"},{"key":"12040591_CR6","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1111\/j.1365-2265.2008.03342.x","volume":"70","author":"AD Anastasilakis","year":"2009","unstructured":"Anastasilakis AD, Goulis DG, Polyzos SA, et al, 2009 No difference between strontium ranelate (SR) and calcium\/vitamin D on bone turnover markers in women with established osteoporosis previously treated with teriparatide: a randomized controlled trial. Clin Endocrinol (Oxf.) 70: 522\u2013526.","journal-title":"Clin Endocrinol (Oxf.)"},{"key":"12040591_CR7","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1097\/TA.0b013e31821957e3","volume":"71","author":"YA Weil","year":"2011","unstructured":"Weil YA, Rivkin G, Safran O, Liebergall M, Foldes AJ, 2011 The outcome of surgically treated femur fractures associated with long-term bisphosphonate use. J Trauma 71: 186\u2013190.","journal-title":"J Trauma"},{"key":"12040591_CR8","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1359\/jbmr.080102","volume":"23","author":"J Lappe","year":"2008","unstructured":"Lappe J, Cullen D, Haynatzki G, Recker R, Ahlf R, Thompson K, 2008 Calcium and vitamin d supplementation decreases incidence of stress fractures in female navy recruits. J Bone Miner Res 23: 741\u2013749.","journal-title":"J Bone Miner Res"},{"key":"12040591_CR9","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1359\/jbmr.090728","volume":"25","author":"M Priemel","year":"2010","unstructured":"Priemel M, von Domarus C, Klatte TO, et al, 2010 Bone mineralization defects and vitamin D deficiency: histomorphometric analysis of iliac crest bone biopsies and circulating 25-hydroxyvitamin D in 675 patients. J Bone Miner Res 25: 305\u2013312.","journal-title":"J Bone Miner Res"},{"key":"12040591_CR10","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.bone.2010.05.015","volume":"47","author":"AV Sloan","year":"2010","unstructured":"Sloan AV, Martin JR, Li S, Li J, 2010 Parathyroid hormone and bisphosphonate have opposite effects on stress fracture repair. Bone 47: 235\u2013240.","journal-title":"Bone"},{"key":"12040591_CR11","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.bone.2012.10.006","volume":"52","author":"CY Chiang","year":"2013","unstructured":"Chiang CY, Zebaze RM, Ghasem-Zadeh A, Iuliano-Burns S, Hardidge A, Seeman E, 2013 Teriparatide improves bone quality and healing of atypical femoral fractures associated with bisphosphonate therapy. Bone 52: 360\u2013365.","journal-title":"Bone"},{"key":"12040591_CR12","doi-asserted-by":"publisher","first-page":"4644","DOI":"10.1210\/jc.2004-2489","volume":"90","author":"EP Paschalis","year":"2005","unstructured":"Paschalis EP, Glass EV, Donley DW, Eriksen EF, 2005 Bone mineral and collagen quality in iliac crest biopsies of patients given teriparatide: new results from the fracture prevention trial. J Clin Endocrinol Metab 90: 4644\u20134649.","journal-title":"J Clin Endocrinol Metab"},{"key":"12040591_CR13","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.1002\/jbmr.523","volume":"26","author":"DA Towler","year":"2011","unstructured":"Towler DA, 2011 Skeletal anabolism, PTH, and the bone-vascular axis. J Bone Miner Res 26: 2579\u20132582.","journal-title":"J Bone Miner Res"},{"key":"12040591_CR14","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1007\/s00198-010-1369-0","volume":"22","author":"PJ Marie","year":"2011","unstructured":"Marie PJ, Felsenberg D, Brandi ML, 2011 How strontium ranelate, via opposite effects on bone resorption and formation, prevents osteoporosis. Osteoporos Int 22: 1659\u20131667.","journal-title":"Osteoporos Int"},{"key":"12040591_CR15","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1359\/jbmr.071012","volume":"23","author":"ME Arlot","year":"2008","unstructured":"Arlot ME, Jiang Y, Genant HK, et al, 2008 Histomorphometric and microCT analysis of bone biopsies from postmenopausal osteoporotic women treated with strontium ranelate. J Bone Miner Res 23: 215\u2013222.","journal-title":"J Bone Miner Res"},{"key":"12040591_CR16","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1359\/jbmr.070607","volume":"22","author":"P Ammann","year":"2007","unstructured":"Ammann P, Badoud I, Barraud S, Dayer R, Rizzoli R, 2007 Strontium ranelate treatment improves trabecular and cortical intrinsic bone tissue quality, a determinant of bone strength. J Bone Miner Res 22: 1419\u20131425.","journal-title":"J Bone Miner Res"},{"key":"12040591_CR17","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1359\/JBMR.050405","volume":"20","author":"D Farlay","year":"2005","unstructured":"Farlay D, Boivin G, Panczer G, Lalande A, Meunier PJ, 2005 Long-term strontium ranelate administration in monkeys preserves characteristics of bone mineral crystals and degree of mineralization of bone. J Bone Miner Res 20: 1569\u20131578.","journal-title":"J Bone Miner Res"},{"key":"12040591_CR18","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/s00223-009-9317-8","volume":"86","author":"B Habermann","year":"2010","unstructured":"Habermann B, Kafchitsas K, Olender G, Augat P, Kurth A, 2010 Strontium ranelate enhances callus strength more than PTH 1\u201334 in an osteoporotic rat model of fracture healing. Calcif Tissue Int 86: 82\u201389.","journal-title":"Calcif Tissue Int"},{"key":"12040591_CR19","doi-asserted-by":"publisher","first-page":"2816","DOI":"10.1210\/jc.2004-1774","volume":"90","author":"JY Reginster","year":"2005","unstructured":"Reginster JY, Seeman E, De Vernejoul MC, et al, 2005 Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral osteoporosis (TROPOS) study. J Clin Endocrinol Metab 90: 2816\u20132822.","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Hormones"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.14310\/horm.2002.1448.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.14310\/horm.2002.1448\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.14310\/horm.2002.1448.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,9]],"date-time":"2025-02-09T15:37:25Z","timestamp":1739115445000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.14310\/horm.2002.1448"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["12040591"],"URL":"https:\/\/doi.org\/10.14310\/horm.2002.1448","relation":{},"ISSN":["1109-3099","2520-8721"],"issn-type":[{"value":"1109-3099","type":"print"},{"value":"2520-8721","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"17 September 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}